The purpose of this study is to see if a drug called seltorexant (JNJ-42847922) added to your current antidepressant treatment would help to improve your depression and your sleep problems (such as difficulty falling asleep, staying asleep, waking up too early or otherwise poor-quality sleep). The effects of seltorexant will be compared to the effects of placebo (pill without a medicine in it).
CONTACT US ABOUT MDD INSOMNIA TRIALMajor Depressive Disorder with Insomnia
Description
Eligibility Criteria
18-74 Years Old; Diagnosed with Major Depressive Disorder; Have an inadequate response to at least 1 but no more than 2 antidepressants; BMI between 18.0 and 40.0 kg
Duration
This study consists of 2 parts called Part 1 and Part 2. Part 1 takes approximately 3 months. You may be in this study for up to 36 months. Once you have completed Part 1 of the study, your study doctor will assess whether you are able to continue in Part 2 of the study.
Intervention
The sponsor provides the investigational study drug, called "seltorexant" or a placebo. You will receive blister packs with pills. You will need to take one pill once per day with water. The pill must be swallowed whole and not chewed, divided, dissolved, or crushed.
Compensation
You will be reimbursed $100.00 per office visit and $25.00 per telephone contact
Categories
- Adult Clinical Trial